摘要
目的探讨辛伐他汀联合低分子肝素钠治疗冠心病心绞痛的临床效果。方法选取本院100例确诊冠心病心绞痛患者作为目标人群,前瞻性分析且随机分为实验组与对照组,每组50例。比较两组患者治疗后的临床疗效。结果实验组治疗后显效率、有效率、总有效率明显高于对照组,无效率明显低于对照组(P<0.05);实验组TC、TG水平及心绞痛复发次数明显低于对照组(P<0.05);实验组硝酸甘油使用量显著低于对照组(P<0.01)。结论辛伐他汀联合低分子肝素钠治疗冠心病心绞痛临床效果显著。
Objective To discuss the clinical effect of simvastatin and low molecular weight heparin in treatment of angina pectoris. Methods A total of 100 cases diagnosed in our hospital as a target population of patients with angina pectoris were selected, and they were prospective analyzed and randomly divided into two groups, the experimental group and the control group, each group of 50 people. The two groups of patients of the clinical efficacy were compared. Results The rates of markedly effective, efficient and total efficiency of the experimental group were significantly higher than those of control group, no efficient rate of experimental group were significantly lower than that of control group（P〈0.05）; The TC, TG levels and the number of recurrent angina of experimental group were significantly lower than the control group（P〈0.05）; The use of nitroglycerin in patients of the experimental group was significantly lower than the control group（P〈0.01）. Conclusion Simvastatin and low molecular weight heparin in treatment of angina pectoris has significant clinical effect, with reference.
出处
《中国现代医生》
2015年第18期30-32,共3页
China Modern Doctor
关键词
辛伐他汀
氟哌啶醇
冠心病
心绞痛
Simvastatin
Haloperidol
Coronary heart disease
Angina
